Delilah Alvarado's articles Biotechnology FDA adds warning to RSV shots from GSK, Pfizer The regulator is requiring labeling that warns of Guillan-Barré syndrome, although it said data don’t prove a causal link and affirmed the shots’ benefit outweighs their risks. Written by Delilah Alvarado January 9, 2025January 9, 2025 Saving Bookmark this article Bookmarked Biotechnology Moderna, trailing rivals, checks its RSV shot expectations During an investor presentation Thursday, executives admitted to being overly optimistic their vaccine could wrest significant market share away from GSK's and Pfizer's products this year. Written by Delilah Alvarado September 14, 2024September 14, 2024 Saving Bookmark this article Bookmarked Biotechnology Pfizer launches DTC service for migraine, COVID drugs The platform is similar in concept to a service launched this year by Eli Lilly, and aims to give consumers easier access to Pfizer’s migraine, COVID-19 and flu treatments. Written by Delilah Alvarado August 28, 2024August 28, 2024 Saving Bookmark this article Bookmarked Biotechnology Valneva’s chikungunya vaccine approved by FDA The preventive shot is the first to receive regulatory approval for the mosquito-borne illness, which is growing in prevalence worldwide. Written by Delilah Alvarado November 10, 2023November 10, 2023 Saving Bookmark this article Bookmarked Biotechnology Moderna adjusts to changing outlook for COVID vaccine demand The company recorded a net loss in the third quarter as it “resizes” its manufacturing footprint, and now expects revenue to come in at low end of its previous guidance. Written by Delilah Alvarado November 5, 2023November 5, 2023 Saving Bookmark this article Bookmarked Biotechnology Pfizer RSV vaccine gets off to fast start on market The pharma’s shot Abrysvo made over $300 million in sales during the first few months of its launch, and will be an important product to help offset declining COVID vaccine sales. Written by Delilah Alvarado October 31, 2023October 31, 2023 Saving Bookmark this article Bookmarked
Biotechnology FDA adds warning to RSV shots from GSK, Pfizer The regulator is requiring labeling that warns of Guillan-Barré syndrome, although it said data don’t prove a causal link and affirmed the shots’ benefit outweighs their risks. Written by Delilah Alvarado January 9, 2025January 9, 2025 Saving Bookmark this article Bookmarked
Biotechnology Moderna, trailing rivals, checks its RSV shot expectations During an investor presentation Thursday, executives admitted to being overly optimistic their vaccine could wrest significant market share away from GSK's and Pfizer's products this year. Written by Delilah Alvarado September 14, 2024September 14, 2024 Saving Bookmark this article Bookmarked
Biotechnology Pfizer launches DTC service for migraine, COVID drugs The platform is similar in concept to a service launched this year by Eli Lilly, and aims to give consumers easier access to Pfizer’s migraine, COVID-19 and flu treatments. Written by Delilah Alvarado August 28, 2024August 28, 2024 Saving Bookmark this article Bookmarked
Biotechnology Valneva’s chikungunya vaccine approved by FDA The preventive shot is the first to receive regulatory approval for the mosquito-borne illness, which is growing in prevalence worldwide. Written by Delilah Alvarado November 10, 2023November 10, 2023 Saving Bookmark this article Bookmarked
Biotechnology Moderna adjusts to changing outlook for COVID vaccine demand The company recorded a net loss in the third quarter as it “resizes” its manufacturing footprint, and now expects revenue to come in at low end of its previous guidance. Written by Delilah Alvarado November 5, 2023November 5, 2023 Saving Bookmark this article Bookmarked
Biotechnology Pfizer RSV vaccine gets off to fast start on market The pharma’s shot Abrysvo made over $300 million in sales during the first few months of its launch, and will be an important product to help offset declining COVID vaccine sales. Written by Delilah Alvarado October 31, 2023October 31, 2023 Saving Bookmark this article Bookmarked
